alexa The Diagnostic Potential Of Circulating MicroRNA-21 In Hepatocellular Carcinoma Egyptian Patients
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

16th Global Annual Oncologists Meeting
April 24-25, 2017 Dubai, UAE

Mai Zahra
Alexandria Univeristy, Egypt
Posters & Accepted Abstracts: J Cancer Sci Ther
DOI: 10.4172/1948-5956-C1-097
Background: Hepatocellular carcinoma (HCC) is the second most common cause of death from cancer worldwide. In Egypt, the burden of HCC has been increasing with a doubling in the incidence rate in the past decade. One of the reasons for the high mortality in HCC is that the tumors are frequently detected at a stage when curative resection is no longer feasible. Therefore, there is an urgent need to identify novel biomarkers with high efficacy for early detection of HCC. The present study was designed to validate the role of serum miRNA 21 expression in diagnosis of HCC in Egyptian patients. Methods: A total of 60 serum samples (20 samples from HCC patients, 20 samples from cirrhotic patients and 20 samples from healthy volunteers) were collected. The serum expression level of miR-21 was detected by real time quantitative reversetranscriptase PCR (RT-qPCR). Results: Serum miRNA-21 levels in patients with HCC were significantly higher than in cirrhotic patients and control group. ROC analyses for the diagnostic power of serum miRNA-21 yielded an AUC of 0.881 with 90% sensitivity and 72.5% specificity. Conclusions: In conclusion, serum miRNA 21 expression level was more sensitive and specific biomarker in diagnosis of HCC than the traditional marker, Alpha fetoprotein (AFP). When combined together, AFP and miRNA 21 level showed better sensitivity and specificity in HCC diagnosis. Therefore, serum miRNA 21 can be used as a useful additional biomarker, with AFP for screening of HCC among patients with liver cirrhosis.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version